key topics
navigation
|
Welcome To The Debut
Of Arthritis Practitioner
| | |
Arthritis and chronic joint symptoms affect over 65 million people in the United States, according to statistics from the Centers For Disease Control and Prevention (CDC). Currently, that is one out of every three people and these conditions figure to become even more prevalent with the aging of the population. The CDC estimates that the number of people 65 and over with diagnosed arthritis will double from the 15.7 million that were reported in 2002 to 33.3 million in 2030.
However, despite common misperceptions, arthritis does not primarily affect senior citizens. While it is more common in older adults, the CDC points out that nearly two-thirds of those with arthritis are younger than 65. One cannot understate the impact of this condition on the lives of those who are affected. Thirty-one percent of adults with arthritis have work limitations due to the disease. Arthritis accounts for 750,000 hospitalizations and 36 million outpatient visits each year.
While these statistics paint a gloomy picture, there is some good news. Early diagnosis and appropriate management techniques, such as weight control and regular physical activity, can go a long way toward reducing the pain and disability that accompany arthritis, and help facilitate a better quality of life.
With this in mind, it is clear that nurse practitioners (NPs) and physician assistants (PAs) play a vital role as they are on the frontlines of diagnosing and managing arthritis and other musculoskeletal conditions.
During the course of a day, NPs and PAs elicit important details in the patient history, emphasize the importance of exercise and nutrition in reducing painful arthritis symptoms, and prescribe an appropriate medication for patients who have prescriptions for other ailments. Given the impact of NPs and PAs in combating the symptoms of arthritis and other musculoskeletal conditions, we have created a magazine that is specifically tailored to their needs.
Arthritis Practitioner will offer pertinent columns and informative features with an easy to read, active voice tone and an eye-catching design. Our goal is to make it easier for readers to quickly obtain clinical pearls and practice management insights from articles and put them into use.
With this in mind, our debut issue offers the timely cover story, “NSAIDs: Where Do We Go From Here”, the pertinent panel discussion in our “Osteoarthritis Q&A” column and a review of emerging therapies in the feature article “What You Should Know About New Antirheumatic Medications”, just to name a few highlights.
Please let us know your thoughts on the first issue. We look forward to providing the most informative and practical publication in the field. |
|
| Arthritis Practitioner - ISSN: 1 - Volume 1 - Issue 1: May 2005 - May 2005 - Pages: - | |
|
A complimentary CME Webcast Event
To register for this Web Archive program, click on Complimentary CME Webcast Event
This activity is for nurse practitioners, physician assistants, rheumatologists and internal medicine
physicians who treat patients with rheumatoid arthritis (RA).
Panelists/Lectures
"What You Should Know About Treating Early RA"
Nathan Wei, MD
Clinical Director
Arthritis and
Osteoporosis Center
Frederick, Md.
"A Closer Look At The Efficacy And Safety Of Combination Therapy With Anti-TNF Agents"
Philip Mease, MD
Clinical Professor
University of Washington
School of Medicine
Chief, Rheumatology Clinical Research
Swedish Hospital Medical Center
Seattle
"What The Studies Reveal About Emerging Therapies For RA"
Salahuddin Kazi, MD
Chief of Rheumatology
Presbyterian Hospital
Dallas,Tx.
This activity is supported by an educational grant from Genentech and Biogen Idec. The activity is sponsored by the North American Center for Continuing Medical Education (NACCME).
A complimentary CME Webcast Event
ON DEMAND
(Q&A with panelists to follow lectures)
To register for this Webcast program, click on Complimentary CME Webcast
This activity is geared to physicians, rheumatologists, nurses, physician assistants and nurse practitioners who treat rheumatoid arthritis.
Agenda And Faculty
“Treating RA: The Shift To A More Aggressive Therapeutic Approach”
Linda Davis, MHS, PA-C
Assistant Professor
University Of North Texas Health Science Center
“What The Literature Reveals About Combination Therapy”
Kevin M. Latinis, MD, PhD
Division of Allergy, Clinical Immunology and Rheumatology
University of Kansas Medical Center
“New Biologic DMARDs: Can They Have An Impact?”
Salahuddin Kazi, MD
Chief of Rheumatology
Presbyterian Hospital
Dallas, Texas
This activity is supported by an educational grant from Bristol-Myers Squibb. The activity is sponsored by the North American Center for Continuing Medical Education (NACCME).
A complimentary CME Web Archive Event
To register for this Web Archive program, click on Complimentary CME Web Archive Event
This activity is geared to physicians, nurses, physician assistants and nurse practitioners who treat osteoarthritis.
Agenda And Faculty
“A Closer Look At The Role Of Intraarticular Injections”
Frank Caruso, PA-C
Physician Assistant
Wake Forest University Baptist Medical Center
Winston-Salem, NC
“What The Literature Reveals About Viscosupplementation”
Nathan Wei, MD
Clinical Director
Arthritis and Osteoporosis Center
Frederick, MD
“Mastering The Technique Of Intraarticular Injections”
Mike Rudzinski, PA-C
Physician Assistant
Buffalo Veterans Affairs Medical Center
Buffalo, NY
This activity is supported by an educational grant from Genzyme. The activity is sponsored by the North American Center for Continuing Medical Education (NACCME).
A Complimentary CME Webcast Event
A Complimentary, On-Demand CME Webcast
To register for this Webcast program, click on Complimentary CME Webcast Event
This activity is geared to physicians, nurses, physician assistants and nurse practitioners who treat rheumatoid arthritis.
AGENDA and FACULTY
"Reviewing The Role of DMARDs In Treating RA"
Don Flinn, PA-C
Physician Assistant, McBride Clinic, Oklahoma City, Ok.
Vice-President, Society Of Physician Assistants In Rheumatology
"Assessing The Potential of Biologic Therapies"
Mark Genovese, MD
Associate Professor of Medicine
Division of Immunology And Rheumatology
Stanford University School Of Medicine
"What You Should Know About Infusion Therapy"
Nathan Wei, MD
Clinical Director
Arthritis and Osteoporosis Center
Frederick, Md.
This activity is supported by an educational grant from Bristol-Myers Squibb.
The activity is sponsored by the North American Center for Continuing Medical Education (NACCME).
Educational Monographs

In a CME/CE roundtable discussion, expert panelists review the subtypes of JIA, keys to patient adherence and insights on treatments ranging from NSAIDs and methotrexate to emerging biologic agents.
This CME monograph is supported by an educational grant from Abbott Laboratories. It is sponsored by the North American Center for Continuing Medical Education (NACCME).
|